Annoying Biologics the China in conversations with Russia, Brazil, Chile, and Saudi Arabia you start a test phase III study of the experimental vaccine for the COVID-19, said Saturday one of its founders.
The official figures from China, are successful, according to the reports for the reduction of infections, the evaluate made difficult by COVID-19, the testing of large-scale vaccine, you need a population that is affected by the pandemic are to their effectiveness. So far, only few countries have agreed to work with her.
“We will Arabia, the contact with Russia, Brazil, Chile, and Saudi (for the phase III study) and it is still in the discussion“said Qiu Dongxu, executive chairman and co-founder of the Annoying, in a conference on the development of antiviral drugs in Suzhou, in the East of China.
Qiu said that it is likely to start the Tests of the phase III, “very soon” and to recruit the company’s plans than 40,000 participants.
Your candidate COVID-19, Ad5-nCov, was to move the first in China to human testing in March, but behind other potential vaccines in relation to the progress of the studies: two experimental vaccines developed by Sinovac Biotech, a unit of the pharmaceutical group, China National (Sinopharm) have already been approved for the phase III studies.
Qiu said that its phase II study with 508 people, has given Results “significantly better” than that of phase I in respect of the safety of vaccines and the ability to make an immune response to triggerbut not to reveal a concrete evidence.
Despite the fact that the results were not yet published, in June, Beijing announced that it would start for this experimental vaccine, to your army.
The Board said that the new factory will enable the construction in China to produce 100 to 200 million doses of vaccine against the coronavirus of the year at the beginning of 2021.
The Chinese army, whose research group works on the development of the vaccine candidate, has approved their use by the military in the past month, while the two experimental vaccines in Sinopharm, the employees of state-owned enterprises offer, traveling to foreign countries.
Brazil, the home of several essays
The South American giant, the second most affected country by the pandemic, according to the United States, in contact with several projects of the vaccine. At the beginning of July, the tests, the Chinese company Sinovac passed and that it is to 9,000 volunteers in six States (são Paulo, Brasília, Rio de Janeiro, Minas Gerais, Rio Grande do Sul and Paraná).
In addition, Brazil is also developed with the consideration of a possible vaccine by the pharmaceutical company AstraZeneca, with researchers from the University of Oxford, which, according to the World Health organization (WHO) is the main candidate in the world and the most advanced in terms of development, with nearly 2,000 participants. For this project, the government of Jair Bolsonaro has already an agreement with the University of Oxford, the 100 million vaccines against the coronavirus. The Deputy Minister of health, élcio Franco, announced the Pact. “For the purchase of three lots, of which the first delivery in December more”. The British University of the test in Brazilian territory is
On the last day in Brazil included 1.071 deaths per COVID-19 with the balance sheet total of victims up to 71.469while the number of cases already exceeds the 1.83 million infected.
(With information from Reuters)
FOR MORE ON THIS TOPIC:
Bill Gates: “If the vaccines against the coronavirus is the leading ones, the more silver the pandemic becomes more and more deadly”
A virologist, he fled the withheld information on the coronavirus: “you could be rescued from China and showed how the regime of thousands of lives”